Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $65.3000 (-0.79%) ($64.9100 - $66.8100) on Wed. Jan. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2% (three month average) | RSI | 46 | Latest Price | $65.3000(-0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 1.2% a day on average for past five trading days. | Weekly Trend | BAX declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(52%) XLP(52%) VYM(51%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -1% in a week (0% probabilities). TLT(-19%) DIA(-14%) GDXJ(-11%) VIXM(-9%) XHB(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1% (StdDev 2%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $65.2(0.15%) | 10 Day Moving Average | $64.26(1.62%) | 20 Day Moving Average | $65.24(0.09%) | To recent high | -15.5% | To recent low | 6.3% | Market Cap | $33.315b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |